vatalanib has been researched along with Corneal Angiogenesis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bock, F; Cursiefen, C; Dietrich, T; Hos, D; Kruse, FE; Onderka, J; Thierauch, KH | 1 |
1 other study(ies) available for vatalanib and Corneal Angiogenesis
Article | Year |
---|---|
Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation.
Topics: Animals; Cell Proliferation; Corneal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Graft Survival; Keratoplasty, Penetrating; Lymphangiogenesis; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phosphorylation; Phthalazines; Protein Kinase Inhibitors; Pyridines; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor Receptor-3 | 2008 |